Tech Center 1600 • Art Units: 1600 1633 1635 1657
This examiner grants 0% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17937614 | THERMAL STATE SWITCHES IN MACROPHAGES | Non-Final OA | California Institute of Technology |
| 18357495 | RNAI CONSTRUCTS AND METHODS FOR INHIBITING FAM13A EXPRESSION | Non-Final OA | AMGEN INC. |
| 18254893 | COMPOSITIONS AND USES THEREOF FOR TREATMENT OF ANGELMAN SYNDROME | Non-Final OA | The Trustees of the University of Pennsylvania |
| 18375206 | OCULAR DELIVERY OF OLIGONUCLEOTIDES | Non-Final OA | UNIVERSITY OF MASSACHUSETTS |
| 17917953 | ANTISENSE SEQUENCES FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS | Non-Final OA | SORBONNE UNIVERSITE |
| 18031547 | COMPOSITIONS AND METHODS FOR TREATING GLYCOGEN STORAGE DISEASE TYPE 1A | Non-Final OA | Beam Therapeutics Inc. |
| 18280779 | Methods for Delivering a Cargo Into a Cell | Non-Final OA | TRINCE BV |
| 18455035 | TECHNOLOGY PLATFORM OF UNCAPPED-LINEAR MRNA WITH UNMODIFIED URIDINE | Non-Final OA | Binhui Biopharmaceutical Co., Ltd |
| 18363976 | ENGINEERED LEUCINE DECARBOXYLASES | Non-Final OA | Syntis Bio , Inc. |
| 18254086 | CRISPR RIBONUCLEOPROTEIN COMPLEX GENOME EDITING OF HUMAN INNATE IMMUNE CELLS | Non-Final OA | The Regents if the University of California |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy